Entero Healthcare Solutions Ltd. (ENTERO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Entero Healthcare Solutions Ltd. (ENTERO) has a cash flow conversion efficiency ratio of -0.032x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-572.73 Million ≈ $-6.19 Million USD) by net assets (Rs17.97 Billion ≈ $194.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ENTERO market cap overview for the company's overall valuation and market capitalisation.
Entero Healthcare Solutions Ltd. - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Entero Healthcare Solutions Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Entero Healthcare Solutions Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Entero Healthcare Solutions Ltd. ranked by their cash flow conversion efficiency. Explore Entero Healthcare Solutions Ltd. earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cangzhou Dahua Co Ltd
SHG:600230
|
0.018x |
|
Anteris Technologies Global Corp. Common Stock
NASDAQ:AVR
|
-0.083x |
|
Shandong Xiantan Co Ltd
SHE:002746
|
0.053x |
|
ZhuZhou QianJin Pharmaceutical Co Ltd
SHG:600479
|
0.084x |
|
American Public Education Inc
NASDAQ:APEI
|
0.039x |
|
Verusa Holding AS
IS:VERUS
|
-0.014x |
|
Jiangsu Allfavor Intelligent Circuits Technology CO.Ltd
SHE:300964
|
0.006x |
|
IRPC Public Company Limited
BK:IRPC-R
|
0.028x |
Annual Cash Flow Conversion Efficiency for Entero Healthcare Solutions Ltd. (2019–2025)
The table below shows the annual cash flow conversion efficiency of Entero Healthcare Solutions Ltd. from 2019 to 2025. View Entero Healthcare Solutions Ltd. (ENTERO) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | Rs17.53 Billion ≈ $189.53 Million |
Rs693.22 Million ≈ $7.50 Million |
0.040x | +187.18% |
| 2024-09-30 | Rs17.70 Billion ≈ $191.46 Million |
Rs-803.24 Million ≈ $-8.69 Million |
-0.045x | -103.41% |
| 2023-09-30 | Rs16.41 Billion ≈ $177.51 Million |
Rs-366.12 Million ≈ $-3.96 Million |
-0.022x | +69.10% |
| 2022-09-30 | Rs6.28 Billion ≈ $67.89 Million |
Rs-453.15 Million ≈ $-4.90 Million |
-0.072x | -15.29% |
| 2021-09-30 | Rs5.63 Billion ≈ $60.91 Million |
Rs-352.66 Million ≈ $-3.81 Million |
-0.063x | +55.60% |
| 2020-09-30 | Rs4.87 Billion ≈ $52.67 Million |
Rs-686.84 Million ≈ $-7.43 Million |
-0.141x | -63.81% |
| 2019-09-30 | Rs4.24 Billion ≈ $45.88 Million |
Rs-365.19 Million ≈ $-3.95 Million |
-0.086x | -- |
About Entero Healthcare Solutions Ltd.
Entero Healthcare Solutions Limited engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. The company involved in the distribution of generic formulations, active pharmaceutical ingredients, surgical consumables, rehabilitation products and devices, over the counter medical products, nutraceuticals, biosimilars, and biologics. It also p… Read more